Spring training is in full swing, and the Supreme Court umpire has left the pharmaceutical industry stuck between the bases. Yesterday's ruling must have drugmakers like Pfizer
Diana Levine sued Wyeth
Unfortunately for Wyeth and the rest of the drug industry, the Supreme Court disagreed. The court basically said that the FDA's actions on drugs could supersede state law, but Congress would need to write that into law like it did for medical devices.
Good luck with that. Medical device makers like Boston Scientific
However, it looks like Congress might take that away -- Congressmen Henry Waxman and others want a law to overturn the Supreme Court ruling. Given that, it looks like it would be an uphill battle to get Congress to protect the pharmaceutical companies in a similar manner.
So, drug companies are stuck with no place to hide. I doubt they'll take action to unilaterally change their labels and risk the FDA pulling rank, so they'll basically be left to potentially be sued for any warning not on their label.
And investors will be left footing the bill. Thanks a lot, Supreme Court.
Intuitive Surgical is a Rule Breakers selection. Pfizer is a former Income Investor selection and a current pick of the Inside Value newsletter. Try any of our Foolish newsletters today, free for 30 days.
Fool contributor Brian Orelli, Ph.D., likes baseball and bashing government entities. He doesn't own shares of any company mentioned in this article. If you read the Fool's disclosure policy while cross eyed standing on your head, it might give you a headache. Consider yourself warned.
More from The Motley Fool
People's United Financial, Inc. (PBCT) Q4 2017 Earnings Conference Call Transcript
PBCT earnings call for the period ending December 31, 2017.
IBM Struggled With the Tax Man in the 4th Quarter
A long-awaited return to actual sales growth was overshadowed by a $5.5 billion one-time tax charge.
1 Big Improvement That Apple Needs to Bring to the New iPhone SE
It's time for a new display.